Atagabalin HCl

CAS No. 223445-67-8

Atagabalin HCl( —— )

Catalog No. M34510 CAS No. 223445-67-8

Atagabalin HCl is a novel voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) ligand that affects slow-wave sleep and can be used to treat insomnia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 1449 Get Quote
5MG 1786 Get Quote
10MG 2442 Get Quote
25MG 3514 Get Quote
50MG 4738 Get Quote
100MG 6255 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Atagabalin HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Atagabalin HCl is a novel voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) ligand that affects slow-wave sleep and can be used to treat insomnia.
  • Description
    Atagabalin HCl is a novel voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) ligand that affects slow-wave sleep and can be used to treat insomnia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    223445-67-8
  • Formula Weight
    221.72
  • Molecular Formula
    C10H20ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(CC1(C[C@@H]([C@H](C1)C)C)CN)=O.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Atagabalin

    Atagabalin (PD 0200390) is a novel ligand of the voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) for treatment for insomnia.

  • Clopimozide

    Clopimozide (R-29764) acts as a calcium channel antagonist and inhibits [3H] nilandipine binding.

  • Nexopamil

    Nexopamil (LU-49938) is a calcium channel antagonist and a 5-hydroxytryptamine 2A receptor antagonist.